GlassScriptPhysician profile
Mardon R Day
NPI 1245214899
$4,073.34
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $820 · 2020: $384 · 2021: $777 · 2022: $1,126 · 2023: $799 · 2024: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $867.85 | 2019-2023 | Grafix, Stravix, Stravix Pl |
| Organogenesis INC. | $820.19 | 2021-2023 | Puraply |
| Kerecis Limited | $462.88 | 2019-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Melinta Therapeutics, LLC | $227.78 | 2019-2022 | |
| Medtronic, INC. | $187.73 | 2022-2024 | Intellis Adaptivestim |
| Stryker Corporation | $179.86 | 2022-2023 | Phalinx, Augment Injectable, Variax |
| Paratek Pharmaceuticals, INC. | $167.22 | 2019-2023 | Nuzyra |
| Horizon Therapeutics Plc | $123.64 | 2019-2023 | Krystexxa |
| Abbvie INC. | $116.26 | 2021-2024 | |
| Aroa Biosurgery Incorporated | $111.00 | 2022-2024 | |
| Nevro Corp. | $98.17 | 2022-2023 | Senza |
| Acera Surgical, INC. | $69.74 | 2019-2023 | Restrata Wound Matrix |
| Molnlycke Health Care US, LLC | $66.21 | 2020 | |
| Integra Lifesciences Corporation | $50.14 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $48.82 | 2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $41.34 | 2019 | |
| Treace Medical Concepts, INC. | $37.80 | 2022-2023 | |
| Zyla Life Sciences, INC. | $35.83 | 2019-2020 | |
| Convatec INC. | $34.48 | 2023 | |
| Orthofix Medical, INC. | $34.25 | 2019-2020 | |
| Paragon 28, INC. | $33.48 | 2021-2022 | |
| Sandoz INC. | $31.71 | 2019 | |
| Depuy Synthes Sales INC. | $31.31 | 2021 | |
| Djo, LLC | $27.61 | 2023 | Cmf |
| Merck Sharp & Dohme LLC | $27.34 | 2019 | |
| Polynovo North America LLC | $27.21 | 2022 | |
| Nabriva Therapeutics, Plc | $26.04 | 2021-2022 | |
| Triad Life Sciences INC. | $25.88 | 2021-2022 | |
| Polarityte, INC. | $20.78 | 2019 | |
| Misonix INC | $13.76 | 2019 | |
| Alfasigma USA, INC. | $13.57 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mardon Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.